靶点- |
作用机制- |
|
|
|
非在研适应症- |
最高研发阶段临床1期 |
首次获批国家/地区- |
首次获批日期- |
A Phase 1 Study to Evaluate Safety and Tolerability of Single and Multiple Ascending Doses of XEN-101
The goal of this study is to assess the safety and tolerability of single and multiple ascending doses of XEN-101
100 项与 Xeno Biosciences, Inc. 相关的临床结果
0 项与 Xeno Biosciences, Inc. 相关的专利(医药)
100 项与 Xeno Biosciences, Inc. 相关的药物交易
100 项与 Xeno Biosciences, Inc. 相关的转化医学